Commentary on “Exosome-mediated stable epigenetic repression of HIV-1”

Abstract

Extracellular vesicles (EVs) were first described in the 1980s. An area of interest in immunology is the influence of a subset of EVs (exosomes) on the course of human disease and their centrality in the anti-human immunodeficiency virus (HIV) mitigation process. In this commentary, we dissect work published by Shrivastava et al., on exosome-mediated stable epigenetic repression of HIV-1.